Follow
Ritwik Sinha
Title
Cited by
Cited by
Year
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who …
K Porkka, HJ Khoury, RL Paquette, Y Matloub, R Sinha, JE Cortes
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
2042010
Artificial intelligence: How is it changing medical sciences and its future?
K Basu, R Sinha, A Ong, T Basu
Indian journal of dermatology 65 (5), 365-370, 2020
1622020
Dasatinib 2-year efficacy in patients with chronic-phase chronic myelogenous leukemia (CML-CP) with resistance or intolerance to imatinib (START-C)
MJ Mauro, M Baccarani, F Cervantes, JH Lipton, Y Matloub, R Sinha, ...
Journal of Clinical Oncology 26 (15_suppl), 7009-7009, 2008
992008
Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study
BA Rybicki, R Sinha, S Iyengar, C Gray-McGuire, RC Elston, MC Iannuzzi
Genes & Immunity 8 (5), 379-386, 2007
562007
Predicting reactions to short-text posts
BV Srinivasan, A Natarajan, R Sinha, V Gupta, SV Revankar, B Ravindran
US Patent 9,256,826, 2016
472016
Time-uniform central limit theory and asymptotic confidence sequences
I Waudby-Smith, D Arbour, R Sinha, EH Kennedy, A Ramdas
arXiv preprint arXiv:2103.06476, 2021
41*2021
Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5
C Gray-McGuire, R Sinha, S Iyengar, C Millard, BA Rybicki, RC Elston, ...
Human genetics 120, 420-430, 2006
402006
Dasatinib time to and durability of major and complete cytogenetic response (MCyR and CCyR) in patients with chronic myeloid leukemia in chronic phase (CML-CP)
M Baccarani, G Rosti, G Saglio, J Cortes, R Stone, DW Niederwieser, ...
Blood 112 (11), 450, 2008
392008
Optimal time to post for maximum social engagement
BV Srinivasan, N Anandhavelu, R Sinha, S Revankar
US Patent 9,607,273, 2017
342017
Saliency prediction for a mobile user interface
P Gupta, S Pal, S Gupta, R Sinha, A Jayagopal
US Patent 10,664,999, 2020
312020
Identifying sources of anomalies in multi-variable metrics using linearization
SK Saini, R Sinha, M Rimer, N Anandhavelu
US Patent 10,404,777, 2019
292019
A non-parametric approach to the multi-channel attribution problem
MM Yadagiri, SK Saini, R Sinha
Web Information Systems Engineering–WISE 2015: 16th International Conference …, 2015
272015
Marketing channel attribution
R Sinha, SK Saini, N Anandhavelu
US Patent App. 14/508,141, 2016
222016
Probabilistic deduplication of anonymous web traffic
R Saha Roy, R Sinha, N Chhaya, S Saini
Proceedings of the 24th International Conference on World Wide Web, 103-104, 2015
222015
Estimating the incremental effects of interactions for marketing attribution
R Sinha, S Saini, N Anadhavelu
2014 International Conference on Behavioral, Economic, and Socio-Cultural …, 2014
202014
Dasatinib-Associated Major Molecular Responses Are Rapidly Achieved in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Following Resistance, Suboptimal …
A Hochhaus, MC Müller, J Radich, S Branford, B Hanfstein, P Rousselot, ...
Blood 112 (11), 1095, 2008
192008
A mathematical abstraction for balancing the trade-off between creativity and reality in large language models
R Sinha, Z Song, T Zhou
arXiv preprint arXiv:2306.02295, 2023
182023
Saliency prediction for mobile user interfaces
P Gupta, S Gupta, A Jayagopal, S Pal, R Sinha
2018 IEEE Winter Conference on Applications of Computer Vision (WACV), 1529-1538, 2018
182018
Multiple testing in the genomics era: findings from Genetic Analysis Workshop 15, Group 15
LJ Martin, JG Woo, CL Avery, HS Chen, KE North, Group 15
Genetic Epidemiology 31 (S1), S124-S131, 2007
182007
Will your facebook post be engaging?
BV Srinivasan, A Natarajan, R Sinha, V Gupta, S Revankar, B Ravindran
Proceedings of the 1st workshop on User engagement optimization, 25-28, 2013
162013
The system can't perform the operation now. Try again later.
Articles 1–20